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Congenital diaphragmatic hernia (CDH) is associated with high neonatal mortality from lung hypoplasia
and persistent pulmonary hypertension. Pulmonary neuroendocrine cells (PNEC) produce calcitonin gene-
related peptide (CGRP), a potent vasodilator. We previously reported altered distribution of CGRP-posi-
tive PNEC in full-term rats with CDH, that may lead to an imbalance in vasoactive mediators. In the
present study we examined the expression of CGRP-positive PNEC during lung development in rats with
CDH induced by 2,4-dichlorophenyl-p-nitrophenylether (Nitrofen). Cesarean sections were performed on
Days 16, 18, 20, or 22, and the lungs were immunostained for CGRP and immunoreactive cells were quan-
titated through image analysis. On Day 16, CGRP-immunoreactive staining was negative; on Day 18,
CGRP-immunoreactive cells were found in all controls (not exposed to Nitrofen), whereas in CDH pups,
CGRP-positive cells were present in only four of six cases. On Day 20, CGRP immunoreactivity was sim-
ilar in CDH pups, Nitrofen-exposed pups without CDH, and controls. On Day 22 (term), significantly
more CGRP-positive cells (i.e., number of positive cells per surface area [mm
 
2
 
] or lung volume [mm
 
3
 
])
were found in ipsilateral lungs of CDH pups than in controls (
 
P
 
 
 
,
 
 0.05). The difference was even more
striking in contralateral lungs of CDH pups (
 
P
 
 
 
,
 
 0.001), ruling out nonspecific effects of Nitrofen. In
CDH lungs, the proportion of immunostained epithelium and the size of the neuroendocrine cell clusters
(neuroepithelial bodies [NEB]) were not significantly different from those of controls. On Day 22, supra-
optimal dilution immunocytochemistry yielded similar results in CDH pups and controls. We conclude
that in CDH, CGRP expression in PNEC and NEB is delayed during early stages of lung development. Be-
cause CGRP also exhibits growth factor-like properties for endothelium and epithelial cells, the lack of
this factor during a crucial developmental stage (canalicular period) may be causally related to lung hypo-
plasia. 
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Amine- and peptide-producing pulmonary neuroendo-
crine cells (PNEC) are distributed throughout the airway
mucosa as solitary cells and as innervated clusters, called
neuroepithelial bodies (NEB) (1, 2). PNEC have an im-
portant role during lung development (2, 3) and neonatal
adaptation (2, 4), particularly in the regulation of pulmo-
nary vascular tone (5). Furthermore, NEB are transducers
of the hypoxic stimulus and therefore may function as air-
way chemoreceptors in the regulation of respiration (6).
One of the peptides produced by PNEC is calcitonin
gene-related peptide (CGRP) (7, 8). In humans, CGRP-
immunoreactive cells have been identified from 22 wk of
gestation onward (9), mostly within the epithelium of dis-
tal conducting airways (10). In rat lungs they have been
identified from gestational Day 18, with the greatest ex-
pression near term (4). Several studies have indicated that
CGRP has potent vasodilatory and bronchoconstricting
activity (5, 10, 11). Other biologic activities of CGRP in-
clude stimulation of growth, with effects on endothelial
cells and airway epithelium (12, 13). Increased levels of in-
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tracellular CGRP have been found in lungs of chronically
hypoxic rats (14) and in children with bronchopulmonary
dysplasia (BPD) (15).
Infants with congenital diaphragmatic hernia (CDH)
have abnormal morphologic development of lungs and in-
trapulmonary blood vessels (16, 17). The high neonatal
mortality and morbidity in these infants is ascribed to the
severity of lung hypoplasia and persistent pulmonary hy-
pertension (18). Our previous study in a rat model of CDH
revealed that lungs of full-term rat pups contained rela-
tively more CGRP-immunostained NEB than did lungs of
age-matched controls (19). This finding suggests that NEB
may play a role in the pathogenesis of lung hypoplasia or
may lead to an imbalance of vasoactive mediators in CDH.
The aim of the present study was to investigate the devel-
opmental pattern of pulmonary CGRP-positive cells in
lungs of fetal rats with CDH during different stages of lung
development.
 
Materials and Methods
 
Animal Model
 
Female Sprague–Dawley rats (Harlan Olac, Wichester, UK)
were mated during a period of 1 h (Day 0 of gestation).
Eleven of 19 pregnant rats received 100 mg of 2,4-dichloro-
phenyl-p-nitrophenylether (Nitrofen; Rohm & Haas Co.,
Philadelphia, PA) in 1 ml of olive oil orogastrically under
light ether anesthesia on Day 10 of gestation (20, 21). The
remaining eight rats provided control pups. Nitrofen in-
duces a large left-sided diaphragmatic defect with severe
lung hypoplasia, sometimes in combination with a small
right-sided defect, in up to 80% of offspring of rats treated
with this regimen. Food and water were supplied 
 
ad libi-
tum
 
 throughout the period of pregnancy. The pregnant
dams were anesthetized by inhalation of diethylether, and
a cesarean section was performed on Day 16 (two litters
for each group), Day 18 (three Nitrofen-group litters and
two control-group litters), Day 20 (three Nitrofen-group
litters and two control-group litters), or Day 22 (three Ni-
trofen-group litters and two control-group litters). The fe-
tuses were removed and killed after cervical intersection
with a needle before any breathing occurred. Autopsy re-
vealed a diaphragmatic defect in the Nitrofen-exposed rat
pups. The lungs, with trachea attached, were removed for
histologic examination. Three groups were studied: rat pups
with CDH (Day 16: 
 
n
 
 
 
5
 
 8; Day 18: 
 
n
 
 
 
5
 
 6; Day 20: 
 
n
 
 
 
5
 
 10;
Day 22: 
 
n
 
 
 
5
 
 7) and pups without CDH (non-CDH; Day
16: 
 
n
 
 
 
5
 
 4; Day 18: none; Day 20: 
 
n
 
 
 
5
 
 7; Day 22: 
 
n
 
 
 
5
 
 5) in
the Nitrofen group, and control pups (Day 16: 
 
n
 
 
 
5
 
 5; Day
18: 
 
n
 
 
 
5
 
 8; Day 20: 
 
n
 
 
 
5
 
 4; Day 22: 
 
n
 
 
 
5
 
 4).
The experimental protocol for the study was approved
by the Animal Care and Use Committee of Erasmus Uni-
versity, Rotterdam.
 
Histologic Examination
 
The lung tissue from rat pups was processed according to
Springall and colleagues (14). The lungs were fixed by im-
mersion in Bouin’s fluid, dehydrated in graded ethanols,
and embedded in paraffin, and 4-
 
m
 
m sections were cut.
Immunostaining for CGRP was performed with specific
rabbit polyclonal antibody against rat CGRP (CA-08-220;
Cambridge Research Biochemicals Incorporated, Wil-
mington, DE), using the peroxidase–antiperoxidase method
(22). The optimal dilution of 1:400 of the primary antibody
was used, according to the manufacturer’s instructions.
Counterstaining was performed with hematoxylin.
With the aid of a projecting microscope, the total area
of the lungs and all CGRP-positive areas (both PNEC
[i.e., solitary cells] and NEB [i.e., clusters of three or more
cells]) were traced on paper (magnification: 
 
3
 
700) (23).
Morphometric analysis included measurements of the size
of CGRP-positive areas, the number of CGRP-positive ar-
eas per lung, the total surface area of lung sections, the
CGRP-positive areas of airway epithelium, and the total
epithelial surface area of the immunopositive airways.
These measurements were made with a Macintosh com-
puter (Apple, Inc., Cupertino, CA) and the National Insti-
tutes of Health (NIH, Bethesda, MD) Image 1.53 program.
The resulting data were used to calculate the number of
CGRP-positive areas per mm
 
2
 
 lung (frequency of CGRP-
positive cells) (19), and the epithelial CGRP-positive area
in relation to the total epithelial area, referred to as the
percentage of immunostained epithelium (%IMS-epithe-
lium) (23). The percentage of airways containing CGRP-
positive cells, referred to as immunopositive airways (%IMS-
airways), was determined by counting (24). The size of
CGRP-immunostained NEB, consisting of three or more
cells, was determined by counting the number of nuclei.
The median number of nuclei of the NEB in each case was
used for data analysis.
 
TABLE 1
 
CGRP immunoreactivity in rat lungs on gestational Day 18
 
Control CDH
Left Right Left Right
 
Cases with CGRP-positive PNEC 8/8 7/8 4/6 4/6
Cases with CGRP-positive NEB 7/8 5/8 4/6 3/6
Number of CGRP-positive areas 2.5 (1–6) 2.5 (0–6) 1.5 (0–5) 1 (0–2)
Number of CGRP-positive NEB 2 (0–6) 2 (0-6) 1 (0–4) 0.5 (0–1)
NEB size 4 (3–6) 6 (3–9) 3 (3–5.5) 5 (3–6)
 
Definition of abbreviations:
 
 CDH 
 
5
 
 congenital diaphragmatic hernia; CGRP 
 
5
 
 calcitonin gene-related peptide; NEB 
 
5
 
 neuroepithelial bodies; PNEC 
 
5
 
 pulmo-
nary neuroendocrine cells.
For controls and CDH rat pups, the number of cases in which CGRP-positive PNEC and the number in which CGRP-positive NEB (consisting of three or more
cells) were found, the number of CGRP-positive areas (consisting of PNEC and NEB), the number of CGRP-positive NEB, and the size of the NEB (determined by
the median number of nuclei) are shown for each lung. For all parameters except the number of CGRP-positive cases, the median and range values are indicated.
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Lung sections taken on gestational Days 16 and 18 were
used to establish the presence of CGRP-positive cells. The
median number of nuclei in NEB in lung sections from
Day 18 rat pups was also determined. In addition, the
%IMS-epithelium, %IMS-airways, and median number of
nuclei of NEB were determined in controls and in rat pups
with CDH on gestational Day 22.
 
Supraoptimal Dilution Immunocytochemistry
 
Supraoptimal dilution immunocytochemistry was used to
compare levels of anti-CGRP immunostaining in the
CDH- and the control-group lung sections from gesta-
tional Days 20 and 22 (14, 25). The lung sections used for
this experiment were adjacent to the lung sections de-
scribed earlier. They were stained with a supraoptimal
concentration of primary antibody of 1:24,000, which is a
60-times dilution of the optimal dilution (25), or with a
concentration of 1:60,000, which was the dilution used by
Ebina and colleagues (25). Coverslips were then mounted
on wet sections, which were immediately examined. The
number of CGRP-positive areas per lung and the size of
those areas were determined as described previously.
Thereafter, these sections were reincubated with primary
antibody at the optimal dilution of 1:400. Sections were
then washed, dehydrated, and mounted following counter-
staining with hematoxylin. All sections were then reexam-
ined. The ratio of cells staining with supraoptimally di-
luted versus optimally diluted anti-CGRP, referred to as
the cell count ratio, was considered an index of the level of
intracellular CGRP (25).
 
Data Analysis
 
Values were expressed as means 
 
6
 
 SEM unless stated oth-
erwise. Differences between groups were tested with one-
way analysis of variance (ANOVA), using the Student–
Newman–Keuls test for multiple comparisons, or with the
nonparametric Kruskal–Wallis test if appropriate. The chi-
square test was used for proportions. Paired 
 
t
 
 tests were
used to compare differences between left and right lungs
in individual cases, and to compare differences in size of
CGRP-positive areas following supraoptimal dilution im-
munocytochemistry. Statistical significance was assumed
at the 5% level for the two-tailed condition.
Figure 1. Weak CGRP-positive staining was present in lungs of CDH pups and controls on gestational Day 18, which is indicated here
(arrow) for the left lung in a CDH rat (A). Also shown are representative pictures from left lungs on gestational Day 22 of a CDH rat
(B), of a Nitrofen-exposed pup without CDH (C), and of a control pup (D), showing a central airway with some large NEB (arrows).
The NEB in CDH were bigger and more prominent in the CDH group than in other groups. Counterstaining with hematoxylin. Scale
bars represent 50 mm.
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Results
 
On gestational Day 16, CGRP immunostaining was nega-
tive in lungs of all three groups studied. On Day 18, weak
staining was found in all but one lung of controls and in
only some lungs of CDH rats (Table 1 and Figure 1A).
Both the numbers of cases with positive CGRP immuno-
staining in the left, ipsilateral lungs, and the numbers of
CGRP-positive areas (PNEC and NEB) in the right, con-
tralateral, lungs tended to be lower in CDH than in control
pups, but the difference was not significant (Table 1).
The results of morphometric analysis of lungs from the
rat pups (the left and right lungs combined) on Days 20
and 22 are shown in Figures 2A through 2D. In pups with
CDH, the left lung was significantly smaller than the right
lung at both time points (Day 20: 7.7 
 
6
 
 0.6 versus 9.9 
 
6
 
 0.5
mm
 
2
 
; Day 22: 9 
 
6
 
 0.5 versus 12.5 
 
6
 
 1 mm
 
2
 
). On Day 20 the
mean total lung area was significantly smaller in CDH
pups than in controls (Figure 2A; 
 
P
 
 
 
5
 
 0.006). The mean
number of CGRP-positive areas, their mean size, and their
frequency were not significantly different (Figures 2B, 2C,
and 2D). On both Day 20 and Day 22 there was a tendency
toward a difference in size of CGRP-positive areas among
the three study groups, but this was not significant (
 
P
 
 
 
5
 
0.08 for both gestational ages). On Day 22 the mean fre-
quency of CGRP-positive cells in CDH-pup lungs was sig-
nificantly higher than in the other groups (Figure 2D; 
 
P
 
 
 
5
 
0.003).
Additional measurements of lung sections from Day 22
CDH pups and controls revealed that the percentage of
immunopositive airways was modestly higher in the left
lung in CDH pups than in controls (Table 2; 
 
P
 
 
 
5
 
 0.03). In
neither CDH pups nor controls did any of the PNEC/NEB
parameters show significant differences in the left versus
the right lungs (Table 2).
Histologic examination of lung slides from Day 22 sug-
gested that more prominent and larger NEB were present
in CDH (Figure 1B) than in control pups (Figures 1C and
1D). Therefore, we counted the number of NEB and de-
termined the median number of nuclei in NEB for each
lung. These parameters yielded no statistical differences
between CDH pups and controls (Table 2), but in CDH
pups several large NEB with up to 38 nuclei were found,
whereas the largest NEB in controls contained not more
than 20 nuclei.
Previous studies have shown that between Days 20 and
22, lungs of CDH pups are retarded with respect to the de-
velopment of future air spaces. Lungs of CDH pups there-
fore have a very compact aspect on Day 22 (26). We spec-
ulated that the higher proportion of CGRP-positive cells
in CDH lungs on Day 22 may not have adequately re-
flected their actual number. Therefore, we corrected the
number of CGRP-positive cells for the lung tissue volume,
as reported by Brandsma and coworkers (26). The number
of CGRP-positive cells per mm
 
3
 
 lung tissue was slightly
but significantly higher in the ipsilateral, left lungs of CDH
pups than in those of controls (
 
P
 
 
 
5
 
 0.05; Table 2). When
data for both lungs together were studied, no significant
differences between CDH and control lungs were ob-
served (3.42 
 
6
 
 0.28 cells/mm
 
3
 
 lung tissue and 2.73 
 
6
 
 0.38
cells/mm
 
3
 
 lung tissue, respectively). In CDH lungs, the
number of CGRP-positive cells per mm
 
3
 
 lung tissue was
significantly higher in the left lungs than in the right lungs
(
 
P
 
 
 
,
 
 0.001; Table 2).
Supraoptimal dilution immunocytochemistry with the
 
Figure 2.
 
For controls (
 
open bar
 
), CDH pups (
 
black bar
 
), and Nitrofen-exposed pups without CDH (
 
shaded bar
 
), the means 
 
6
 
 SEM are
shown for the following parameters on gestational Day 20 and Day 22: total lung surface area (
 
A
 
); number of CGRP-positive areas, con-
sisting of PNEC and NEB (
 
B
 
); size of CGRP-positive areas (
 
C
 
); and numbers of PNEC and NEB per mm
 
2
 
 lung area (CGRP-positive
frequency; 
 
D
 
). The numbers of animals per group are indicated in parentheses. *Significantly different from controls on the same gesta-
tional day, 
 
P
 
 
 
,
 
 0.05; **significantly different from both other groups on the same gestational day, 
 
P
 
 
 
,
 
 0.05; 
 
1
 
significantly different from
the same group on Day 22, 
 
P
 
 
 
,
 
 0.05.
 
TABLE 2
 
CGRP immunoreactivity in rat lungs on gestational Day 22
 
Control CDH
Left Right Left Right
 
%IMS-epithelium 6.5 
 
6
 
 0.7 7.5 
 
6
 
 1.1 8 .1
 
 6
 
 0.7 7.5 
 
6
 
 0.7
%IMS-airways 64 
 
6
 
 2 63 
 
6
 
 3 69 
 
6
 
 1* 68 
 
6
 
 3
CGRP-positive NEB 11 
 
6
 
 3 10 
 
6
 
 2 12 
 
6
 
 2 9 
 
6
 
 1
NEB size 4.9 
 
6 
 
0.4 6.1 
 
6
 
 0.8 5.4 
 
6
 
 0.6 4.7 
 
6
 
 0.3
NEB/mm
 
3
 
 lung tissue
 
†
 
3.5
 
 6
 
 0.8 2.1 
 
6
 
 0.3 5.0 
 
6
 
 0.3*
 
‡ 3.4 6 0.3
Definition of abbreviations: CDH 5 congenital diaphragmatic hernia; CGRP 5 calcitonin gene-related peptide; IMS 5 immunostained; NEB 5 neuroepithelial
bodies.
For controls and CDH pups the percentage immunostained airway epithelium, the percentage immunopositive airways, the total number of CGRP-positive NEB
(consisting of three or more cells), and the size of the NEB (determined by the median number of nuclei) are shown for each lung. For all parameters the mean 6
SEM values are indicated.
*Significantly different from left lung in controls; P , 0.05.
†Lung tissue volumes measured by Brandsma and coworkers (26).
‡Significantly different from right lung in CDH; P , 0.001.
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primary antibody diluted 1:24,000 revealed that on gesta-
tional Day 20 the cell count ratio was 87 6 3% in CDH
and 61 6 8% in control pups (Figure 3; P 5 0.01). On Day
22 no such difference was found. The mean size of the
CGRP-positive areas stained with the supraoptimal dilu-
tion of antibody was not different from the mean size after
restaining with the optimal dilution (data not shown). Ex-
periments with a supraoptimal dilution of 1:60,000 showed
a cell count ratio of 25 6 3% in CDH and 29 6 3% in con-
trol pups on Day 20 (P 5 NS), and of 26 6 3% and 23 6
4%, respectively, on Day 22 (P 5 NS). Significantly larger
CGRP-positive areas were found after staining with a dilu-
tion of 1:60,000 than with the optimal dilution in CDH
lungs and controls on Day 20 (Figure 4), and in CDH lungs
on Day 22 (not shown). Representative photographs show
CGRP immunoreactivity in CDH lungs with the supra-
optimal antibody dilution of 1:60,000 (Figure 5A), fol-
lowed by optimal staining (Figure 5B).
Discussion
In the present study we found some delay in the develop-
ment of CGRP-positive PNEC in lungs of rats with CDH
on gestational Day 18, whereas our findings on Days 20
and 22 could indicate that lung development in CDH ac-
celerates toward the end of gestation. 
In rats with normal lung development, NEB have been
identified from gestational Day 15 onward (8, 27). CGRP
immunoreactivity in fetal rats has been observed in cul-
tures starting from Day 15 1 2 (28), and in vivo from Day
18 onward (4). Maximal CGRP immunoreactivity is reached
on gestational Day 20 (4), and decreases rapidly during the
first week after birth (4, 27). Our findings in controls are in
accordance with these observations.
In CDH pups, however, both the number and the size
of the CGRP-positive areas increased significantly be-
tween Day 20 and Day 22. The number of CGRP-positive
PNEC and NEB per mm2 (frequency of CGRP-positive
cells) was significantly greater in the CDH group than in
both other groups on Day 22. This previously described
phenomenon suggests that the PNEC in CDH lungs con-
tain increased levels of CGRP toward the end of gestation
(19, 29). However, the lung tissue from CDH pups had a
more compact appearance on Day 22 (26). The frequency
of CGRP-immunopositive cells therefore may not ade-
quately reflect their actual number. Determination of the
CGRP-positive cell number per mm3 lung tissue, using
Figure 3. The mean 6 SEM percentage of cells that stained fol-
lowing immunostaining with a supraoptimal dilution of the pri-
mary antibody of CGRP (1:24,000) compared with optimal stain-
ing (1:400), referred to as the cell count ratio, is shown for
controls (open bar) and CDH pups (black bar) on gestational
Day 20 and Day 22. The numbers of animals per group are shown
in parentheses. *Significantly different from controls; P 5 0.01.
Figure 4. Mean 6 SEM sizes of CGRP-positive areas are shown
for CDH and control pups on gestational Day 20 after immuno-
staining with a supraoptimal antibody dilution of 1:60,000 (open
bar) followed by staining with the optimal dilution of 1:400 (black
bar). The numbers of animals per group are shown in parenthe-
ses. *Significantly different from staining with the supraoptimal
dilution in the same group at the same gestational age; P , 0.01.
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previously published data on lung tissue volumes on Day
22 (26), confirmed this assumption.
On Day 22 the left, more hypoplastic lung in CDH pups
had a moderately but significantly higher %IMS-airways
than that of controls. In both lungs of CDH pups, larger
and more prominent NEB were present than in control
pups’ lungs, although their mean size and the mean num-
ber of nuclei per NEB were not significantly different. In-
terestingly, hyperplasia of bombesin-immunostained NEB
has been observed in lungs of human cases of CDH (30).
The higher cell count ratio in CDH than in control pups
on gestational Day 20 after immunostaining with a su-
praoptimal dilution of 1:24,000 suggests that more intra-
cellular CGRP was present in the PNEC of CDH pups.
However, the similar cell count ratios at an antibody dilu-
tion of 1:60,000 in CDH and control pups indicate no dif-
ference in CGRP levels. Yamataka and Puri, using a su-
praoptimal dilution of 1:20,000, showed that significantly
more CGRP-positive cells per mm2 lung area were present
in lungs of CDH pups than in controls on Day 21 (29).
This observation is in accordance with our findings on Day
20. That the number of cells staining with supraoptimally
diluted versus optimally diluted anti-CGRP antibody (i.e.,
the cell count ratio) in their study is much lower than in
ours may be due to different methodology, such as the use
of another CGRP antibody and examination of serial sec-
tions.
It remains speculative whether CGRP immunoreactiv-
ity in CDH increases toward the end of gestation, as sug-
gested previously (19, 29). In favor of this assumption are
the higher frequency of CGRP-immunoreactive cells in
CDH pups and the increased numbers of CGRP-positive
airways and CGRP-positive cells per mm3 lung tissue in
the ipsilateral, most hypoplastic lungs in CDH pups. Other
findings suggest, however, that CGRP immunoreactivity is
similar in CDH and control pups, as follows: (1) the total
number of CGRP-positive cells per mm3 lung tissue and
the size of CGRP-positive areas; (2) the proportion of im-
munostained epithelium; and (3) the results of the supra-
optimal dilution experiments on Day 22.
Our present data do not allow for conclusions about the
direct effect of Nitrofen on CGRP gene expression. Ear-
lier reports suggest that Nitrofen itself has a negative ef-
fect on lung development (21, 26), although expression of
the proliferation marker proliferating cell nuclear antigen,
(PCNA) and of differentiation markers such as collagens
III and IV, fibronectin, and laminin did not differ in Nitro-
fen-exposed and control lungs (A. E. Brandsma, personal
communication). Our findings suggest that Nitrofen expo-
sure alone is not sufficient to explain the retarded lung de-
velopment in this CDH model. This assumption is sup-
ported by findings of Brandsma and coworkers (26), who
reported delayed development of air spaces only if CDH
was present.
Altered expression of neuropeptides may lead to ab-
normal function of NEB as O2 sensors in the perinatal pe-
riod (2, 6). Normally, increased O2 tension at birth would
decrease the stimulation of NEB, whereas continued hy-
poxia in CDH would increase stimulation in two possible
ways (31, 32): Mediators with effects on the pulmonary cir-
culation could be released locally, or signaling via innerva-
tion may occur. An imbalance of vasodilatory and vaso-
constrictive neuropeptides may play a role in persistent
pulmonary hypertension in CDH patients (18). The large
CGRP-positive NEB in CDH lungs may contain other
peptides, such as bombesinlike peptides, leu-enkephalin,
endothelin, or serotonin, which may be involved in pulmo-
nary vasoconstriction (7, 33–35).
In conclusion, the present study shows that the devel-
opmental pattern of CGRP immunoreactivity in lungs of
CDH rats differs from that of controls. Our data for Day
18 suggest delayed expression at the late pseudoglandular/
early canalicular stage of lung development in CDH. Dur-
ing this crucial developmental period, with formation of
capillaries and angiogenesis, lack of CGRP may result in
decreased vascularization (12), a feature of pulmonary ab-
normalities in CDH (16, 17). This, and the fact that CGRP
has a role in the regulation of airway epithelial-cell prolif-
eration (13), suggest that CGRP could at this stage act as a
growth factor, as in the case of expression of bombesinlike
peptides in the human lung (36).
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